JNJ vs LLY: Side-by-Side Comparison
Compare Johnson & Johnson (JNJ) and Lilly(Eli) & Company (LLY) side by side: market cap USD 633.19B vs USD 1.08T, P/E 30.4 vs 43.7. Financials, growth and model signals on Bullrun.
| Metric | JNJ | LLY |
|---|---|---|
| Company | Johnson & Johnson | Lilly(Eli) & Company |
| Country / Exchange | United States · NYSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 633.19B | USD 1.08T |
| P/E ratio | 30.4 | 43.7 |
| Dividend yield | 1.99% | 0.53% |
| Valuation model | 3.0% undervalued | 11.4% overvalued |
| Revenue (FY2025) | USD 94.19B | USD 65.18B |
| Revenue growth YoY | +6.0% | +44.7% |
| Net income | USD 26.80B | USD 20.64B |
| Gross margin | 67.9% | 83.0% |
| Diluted EPS | 11.03 | 22.95 |